Tucker L B, Menon S, Schaller J G, Isenberg D A
Division of Pediatric Rheumatology, Floating Hospital, New England Medical Center, Boston, MA 02111, USA.
Br J Rheumatol. 1995 Sep;34(9):866-72. doi: 10.1093/rheumatology/34.9.866.
This study examines the differences which may distinguish systemic lupus erythematosus (SLE) presenting in adult life or childhood. A common database was established, with analysis of clinical, serological and outcome features of a cohort of patients with SLE, with disease diagnosed before the age of 16 (n = 39) or after the age of 16 (n = 165). Disease onset was generally more severe in the childhood-onset patients. Cardiopulmonary disease was more common in the older-onset group, but major haematological manifestations were more frequent in the childhood-onset group. Serologically, anti-DNA, anti-Sm and anti-RNP antibodies and a low C3 were all found more frequently in the younger patients. Twice as many adult-onset cases had died at the time of the last follow-up (10 vs 5%), but this group had been followed for a longer period (average 7.5 yr, S.D. 3.9 for adults vs average 4.8 yr, S.D. 3.2 for children). However, the younger patients were twice as likely (82 vs 40%) to require high-dose prednisone, although the requirement for immunosuppressive agents was similar in the two groups. Clinicians should anticipate that children with SLE have a more severe disease onset than adults in general.
本研究探讨了成年期或儿童期出现的系统性红斑狼疮(SLE)可能存在的差异。建立了一个通用数据库,分析了一组SLE患者的临床、血清学和预后特征,这些患者的疾病诊断年龄在16岁之前(n = 39)或16岁之后(n = 165)。儿童期发病的患者疾病起病通常更严重。心肺疾病在成年期发病组中更常见,但主要血液学表现在儿童期发病组中更频繁。在血清学方面,抗DNA、抗Sm和抗RNP抗体以及低C3在年轻患者中更常见。在最后一次随访时,成年期发病病例的死亡人数是儿童期发病病例的两倍(10%对5%),但成年期发病组的随访时间更长(成年人平均7.5年,标准差3.9;儿童平均4.8年,标准差3.2)。然而,年轻患者需要高剂量泼尼松的可能性是成年患者的两倍(82%对40%),尽管两组对免疫抑制剂的需求相似。临床医生应普遍预期,SLE患儿的疾病起病比成年人更严重。